- Filed
- May 14, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 13, 2026 | 6.94M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 6.94M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 6.87M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $13K |
| Capex | Q1 2026 · Mar 31, 2025 | $45K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$852K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$2.26M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $8.2M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $8.73M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $23.28M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $24.73M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $25.99M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $25.37M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $2.93M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $2.78M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $2.93M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $2.78M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $15.7M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $16.88M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $26.21M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $27.51M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.24 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.05 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.24 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.05 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $1.02M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $953K |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $727K |
| Rd Expense restated | Q1 2026 · Mar 31, 2025 | $734K |
| Net Income | Q1 2026 · Mar 31, 2026 | −$1.66M |
| Net Income | Q1 2026 · Mar 31, 2025 | $360K |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$1.8M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$320K |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $147K |
| Gross Profit restated | Q1 2026 · Mar 31, 2025 | $1.73M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $1.7M |
| Cost Of Revenue restated | Q1 2026 · Mar 31, 2025 | $4.6M |
| Revenue | Q1 2026 · Mar 31, 2026 | $1.84M |
| Revenue restated | Q1 2026 · Mar 31, 2025 | $6.33M |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $181K |